These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12718485)

  • 21. Current issues surrounding women and minorities in drug trials.
    Wermeling DP; Selwitz AS
    Ann Pharmacother; 1993; 27(7-8):904-11. PubMed ID: 8364277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials integrity: a CRO perspective.
    Beach JE
    Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of the institutional review boards in Korea: constitution, operation, and policy for protection of human research participants.
    Kim OJ; Park BJ; Sohn DR; Lee SM; Shin SG
    J Korean Med Sci; 2003 Feb; 18(1):3-10. PubMed ID: 12589079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In order to perform clinical trials efficiently in Japan--important issues in medical institutions raised by the GCP on-site review].
    Akiyama T; Furuta M; Yamada H
    Nihon Kokyuki Gakkai Zasshi; 2006 Aug; 44(8):541-9. PubMed ID: 16972610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compliance with Good Clinical Practice in oncology registration trials in Japan.
    Yonemori K; Hirakawa A; Ando M; Hirata T; Shimizu C; Katsumata N; Tamura K; Fujiwara Y
    Ann Oncol; 2011 Jun; 22(6):1451-1456. PubMed ID: 21119030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Globalization of clinical trials].
    Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Good clinical practice. Requirements for clinical documentation on the introduction of new drugs].
    Dirach J
    Ugeskr Laeger; 1990 Apr; 152(14):992-4. PubMed ID: 2183456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory changes after the enforcement of the new Clinical Trials Act in Japan.
    Nakamura K; Shibata T
    Jpn J Clin Oncol; 2020 Apr; 50(4):399-404. PubMed ID: 32125380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical trial primer: historical perspective and modern implementation.
    Karsh LI
    Urol Oncol; 2012; 30(4 Suppl):S28-32. PubMed ID: 22795078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quality assurance in clinical studies: a necessity].
    Boll M; Binder J; Siegel A; Grundmann R
    Z Exp Chir Transplant Kunstliche Organe; 1990; 23(2):65-72. PubMed ID: 2278157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inconsistency and institutional review boards.
    Goldman J; Katz MD
    JAMA; 1982 Jul; 248(2):197-202. PubMed ID: 7045428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Registering clinical trials.
    Dickersin K; Rennie D
    JAMA; 2003 Jul; 290(4):516-23. PubMed ID: 12876095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research ethics committees in Japan: A perspective from thirty years of experience at Tokushima University.
    Yanagawa H; Katashima R; Takeda N
    J Med Invest; 2015; 62(3-4):114-8. PubMed ID: 26399332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
    Ekimoto H
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials and the new good clinical practice guideline in Japan. An economic perspective.
    Ono S; Kodama Y
    Pharmacoeconomics; 2000 Aug; 18(2):125-41. PubMed ID: 11067647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing the paradigm: new directions in federal oversight of human research.
    Koski G
    J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S2-6. PubMed ID: 14685070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of new Japanese GCP on pharmaceutical-company-directed clinical trials and physician-directed clinical studies in the surgical field].
    Nakajima T
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):685-90. PubMed ID: 9571965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.
    Schulman KA; Seils DM; Timbie JW; Sugarman J; Dame LA; Weinfurt KP; Mark DB; Califf RM
    N Engl J Med; 2002 Oct; 347(17):1335-41. PubMed ID: 12397192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research ethics review at University Eduardo Mondlane (UEM)/Maputo Central Hospital, Mozambique (2013-2016): a descriptive analysis of the start-up of a new research ethics committee (REC).
    Sacarlal J; Muchanga V; Mabutana C; Mabui M; Mariamo A; Cuamba AJ; Fumo LA; Silveira J; Heitman E; Moon TD
    BMC Med Ethics; 2018 May; 19(1):37. PubMed ID: 29792193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent progress and challenges in investigator-driven clinical development of novel drugs and medical devices at the University of Tokyo Hospital].
    Arakawa Y
    Yakugaku Zasshi; 2013; 133(2):201-8. PubMed ID: 23370514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.